Growth Metrics

Sonoma Pharmaceuticals (SNOA) Net Margin: 2011-2012

Historic Net Margin for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Mar 2012 value amounting to -58.02%.

  • Sonoma Pharmaceuticals' Net Margin rose 3728.00% to -54.01% in Q4 2012 from the same period last year, while for Dec 2012 it was -34.71%, marking a year-over-year increase of 2409.00%. This contributed to the annual value of -58.02% for FY2012, which is 2305.00% up from last year.
  • Sonoma Pharmaceuticals' Net Margin amounted to -58.02% in FY2012, which was up 28.44% from -81.07% recorded in FY2011.
  • In the past 5 years, Sonoma Pharmaceuticals' Net Margin ranged from a high of -58.02% in FY2012 and a low of -81.07% during FY2011.
  • Over the past 2 years, Sonoma Pharmaceuticals' median Net Margin value was -69.55% (recorded in 2011), while the average stood at -69.55%.
  • Data for Sonoma Pharmaceuticals' Net Margin shows a peak YoY skyrocketed of 2,305bps (in 2012) over the last 5 years.
  • Sonoma Pharmaceuticals' Net Margin (Yearly) stood at -81.07% in 2011, then surged by 2,305bps to -58.02% in 2012.